nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2E1—type 2 diabetes mellitus	0.14	0.387	CbGaD
Methimazole—CYP1A2—type 2 diabetes mellitus	0.133	0.369	CbGaD
Methimazole—CYP3A4—type 2 diabetes mellitus	0.0881	0.244	CbGaD
Methimazole—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0371	0.0815	CbGbCtD
Methimazole—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0195	0.043	CbGbCtD
Methimazole—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0191	0.042	CbGbCtD
Methimazole—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0175	0.0384	CbGbCtD
Methimazole—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0166	0.0365	CbGbCtD
Methimazole—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0166	0.0365	CbGbCtD
Methimazole—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0162	0.0357	CbGbCtD
Methimazole—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0153	0.0337	CbGbCtD
Methimazole—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0148	0.0326	CbGbCtD
Methimazole—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0141	0.0311	CbGbCtD
Methimazole—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0138	0.0304	CbGbCtD
Methimazole—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0138	0.0304	CbGbCtD
Methimazole—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0127	0.028	CbGbCtD
Methimazole—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0126	0.0278	CbGbCtD
Methimazole—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0125	0.0274	CbGbCtD
Methimazole—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0123	0.0271	CbGbCtD
Methimazole—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0117	0.0256	CbGbCtD
Methimazole—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0113	0.0248	CbGbCtD
Methimazole—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0111	0.0245	CbGbCtD
Methimazole—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0111	0.0244	CbGbCtD
Methimazole—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0105	0.0232	CbGbCtD
Methimazole—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0105	0.023	CbGbCtD
Methimazole—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0102	0.0223	CbGbCtD
Methimazole—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.01	0.0221	CbGbCtD
Methimazole—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00957	0.021	CbGbCtD
Methimazole—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00917	0.0202	CbGbCtD
Methimazole—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00888	0.0195	CbGbCtD
Methimazole—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0085	0.0187	CbGbCtD
Methimazole—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00803	0.0177	CbGbCtD
Methimazole—CYP2C19—Losartan—type 2 diabetes mellitus	0.00778	0.0171	CbGbCtD
Methimazole—CYP1A2—Losartan—type 2 diabetes mellitus	0.00718	0.0158	CbGbCtD
Methimazole—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00707	0.0155	CbGbCtD
Methimazole—CYP2C9—Losartan—type 2 diabetes mellitus	0.00647	0.0142	CbGbCtD
Methimazole—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00609	0.0134	CbGbCtD
Methimazole—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00583	0.0128	CbGbCtD
Methimazole—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00583	0.0128	CbGbCtD
Methimazole—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00552	0.0121	CbGbCtD
Methimazole—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00411	0.00904	CbGbCtD
Methimazole—CYP3A4—Losartan—type 2 diabetes mellitus	0.00376	0.00827	CbGbCtD
Methimazole—Neuropathy peripheral—Gliclazide—type 2 diabetes mellitus	0.00036	0.00296	CcSEcCtD
Methimazole—Jaundice—Gliclazide—type 2 diabetes mellitus	0.000358	0.00294	CcSEcCtD
Methimazole—Vertigo—Pioglitazone—type 2 diabetes mellitus	0.000358	0.00294	CcSEcCtD
Methimazole—Alopecia—Bromocriptine—type 2 diabetes mellitus	0.000355	0.00291	CcSEcCtD
Methimazole—Rash—Tolbutamide—type 2 diabetes mellitus	0.000354	0.00291	CcSEcCtD
Methimazole—Arthralgia—Glipizide—type 2 diabetes mellitus	0.000354	0.0029	CcSEcCtD
Methimazole—Myalgia—Glipizide—type 2 diabetes mellitus	0.000354	0.0029	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Rosiglitazone—type 2 diabetes mellitus	0.000353	0.0029	CcSEcCtD
Methimazole—Headache—Tolbutamide—type 2 diabetes mellitus	0.000352	0.00289	CcSEcCtD
Methimazole—Vertigo—Sitagliptin—type 2 diabetes mellitus	0.000347	0.00285	CcSEcCtD
Methimazole—Leukopenia—Glimepiride—type 2 diabetes mellitus	0.000347	0.00285	CcSEcCtD
Methimazole—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	0.000343	0.00281	CcSEcCtD
Methimazole—Oedema—Glipizide—type 2 diabetes mellitus	0.000339	0.00278	CcSEcCtD
Methimazole—Arthralgia—Pioglitazone—type 2 diabetes mellitus	0.000339	0.00278	CcSEcCtD
Methimazole—Myalgia—Pioglitazone—type 2 diabetes mellitus	0.000339	0.00278	CcSEcCtD
Methimazole—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000335	0.00275	CcSEcCtD
Methimazole—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000334	0.00274	CcSEcCtD
Methimazole—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.000332	0.00273	CcSEcCtD
Methimazole—Hepatitis—Gliclazide—type 2 diabetes mellitus	0.00033	0.00271	CcSEcCtD
Methimazole—Arthralgia—Sitagliptin—type 2 diabetes mellitus	0.000329	0.0027	CcSEcCtD
Methimazole—Myalgia—Sitagliptin—type 2 diabetes mellitus	0.000329	0.0027	CcSEcCtD
Methimazole—Neuropathy peripheral—Orlistat—type 2 diabetes mellitus	0.000327	0.00268	CcSEcCtD
Methimazole—Urticaria—Repaglinide—type 2 diabetes mellitus	0.000326	0.00267	CcSEcCtD
Methimazole—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000325	0.00267	CcSEcCtD
Methimazole—Oedema—Pioglitazone—type 2 diabetes mellitus	0.000325	0.00267	CcSEcCtD
Methimazole—Alopecia—Glyburide—type 2 diabetes mellitus	0.000325	0.00266	CcSEcCtD
Methimazole—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000322	0.00265	CcSEcCtD
Methimazole—Rash—Tolazamide—type 2 diabetes mellitus	0.000322	0.00265	CcSEcCtD
Methimazole—Headache—Tolazamide—type 2 diabetes mellitus	0.00032	0.00263	CcSEcCtD
Methimazole—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00032	0.00263	CcSEcCtD
Methimazole—Rash—Linagliptin—type 2 diabetes mellitus	0.000319	0.00262	CcSEcCtD
Methimazole—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000319	0.00262	CcSEcCtD
Methimazole—Headache—Linagliptin—type 2 diabetes mellitus	0.000317	0.0026	CcSEcCtD
Methimazole—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.000314	0.00258	CcSEcCtD
Methimazole—Vomiting—Acarbose—type 2 diabetes mellitus	0.000312	0.00256	CcSEcCtD
Methimazole—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.00031	0.00254	CcSEcCtD
Methimazole—Rash—Acarbose—type 2 diabetes mellitus	0.00031	0.00254	CcSEcCtD
Methimazole—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000309	0.00254	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.000309	0.00254	CcSEcCtD
Methimazole—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000308	0.00253	CcSEcCtD
Methimazole—Drowsiness—Metformin—type 2 diabetes mellitus	0.000307	0.00252	CcSEcCtD
Methimazole—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.000305	0.0025	CcSEcCtD
Methimazole—Nausea—Tolazamide—type 2 diabetes mellitus	0.000304	0.00249	CcSEcCtD
Methimazole—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000304	0.00249	CcSEcCtD
Methimazole—Hepatitis—Valsartan—type 2 diabetes mellitus	0.000303	0.00249	CcSEcCtD
Methimazole—Somnolence—Glipizide—type 2 diabetes mellitus	0.000301	0.00247	CcSEcCtD
Methimazole—Neuropathy peripheral—Metformin—type 2 diabetes mellitus	0.000301	0.00247	CcSEcCtD
Methimazole—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000301	0.00247	CcSEcCtD
Methimazole—Hepatitis—Orlistat—type 2 diabetes mellitus	0.000299	0.00246	CcSEcCtD
Methimazole—Rash—Nateglinide—type 2 diabetes mellitus	0.000299	0.00245	CcSEcCtD
Methimazole—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000299	0.00245	CcSEcCtD
Methimazole—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000298	0.00245	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.000296	0.00243	CcSEcCtD
Methimazole—Nausea—Acarbose—type 2 diabetes mellitus	0.000292	0.00239	CcSEcCtD
Methimazole—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00029	0.00238	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000287	0.00236	CcSEcCtD
Methimazole—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000286	0.00235	CcSEcCtD
Methimazole—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000286	0.00234	CcSEcCtD
Methimazole—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000284	0.00233	CcSEcCtD
Methimazole—Jaundice—Irbesartan—type 2 diabetes mellitus	0.000283	0.00232	CcSEcCtD
Methimazole—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000281	0.00231	CcSEcCtD
Methimazole—Nausea—Nateglinide—type 2 diabetes mellitus	0.000281	0.00231	CcSEcCtD
Methimazole—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00028	0.0023	CcSEcCtD
Methimazole—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000279	0.00229	CcSEcCtD
Methimazole—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000278	0.00228	CcSEcCtD
Methimazole—Hepatitis—Metformin—type 2 diabetes mellitus	0.000276	0.00227	CcSEcCtD
Methimazole—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000274	0.00225	CcSEcCtD
Methimazole—Myalgia—Glyburide—type 2 diabetes mellitus	0.000272	0.00223	CcSEcCtD
Methimazole—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000272	0.00223	CcSEcCtD
Methimazole—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000271	0.00222	CcSEcCtD
Methimazole—Urticaria—Glipizide—type 2 diabetes mellitus	0.000269	0.00221	CcSEcCtD
Methimazole—Alopecia—Valsartan—type 2 diabetes mellitus	0.000268	0.0022	CcSEcCtD
Methimazole—Neuropathy peripheral—Losartan—type 2 diabetes mellitus	0.000268	0.0022	CcSEcCtD
Methimazole—Jaundice—Losartan—type 2 diabetes mellitus	0.000266	0.00218	CcSEcCtD
Methimazole—Alopecia—Orlistat—type 2 diabetes mellitus	0.000265	0.00217	CcSEcCtD
Methimazole—Oedema—Glyburide—type 2 diabetes mellitus	0.000261	0.00214	CcSEcCtD
Methimazole—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000261	0.00214	CcSEcCtD
Methimazole—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.00026	0.00214	CcSEcCtD
Methimazole—Rash—Repaglinide—type 2 diabetes mellitus	0.000258	0.00212	CcSEcCtD
Methimazole—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000258	0.00212	CcSEcCtD
Methimazole—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000258	0.00212	CcSEcCtD
Methimazole—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000257	0.00211	CcSEcCtD
Methimazole—Headache—Repaglinide—type 2 diabetes mellitus	0.000257	0.00211	CcSEcCtD
Methimazole—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000256	0.0021	CcSEcCtD
Methimazole—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000256	0.0021	CcSEcCtD
Methimazole—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000255	0.00209	CcSEcCtD
Methimazole—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000254	0.00208	CcSEcCtD
Methimazole—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000251	0.00206	CcSEcCtD
Methimazole—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000251	0.00206	CcSEcCtD
Methimazole—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000251	0.00206	CcSEcCtD
Methimazole—Hepatitis—Losartan—type 2 diabetes mellitus	0.000245	0.00201	CcSEcCtD
Methimazole—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000244	0.00201	CcSEcCtD
Methimazole—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000244	0.00201	CcSEcCtD
Methimazole—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000244	0.002	CcSEcCtD
Methimazole—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000244	0.002	CcSEcCtD
Methimazole—Nausea—Repaglinide—type 2 diabetes mellitus	0.000243	0.002	CcSEcCtD
Methimazole—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000243	0.00199	CcSEcCtD
Methimazole—Pruritus—Glipizide—type 2 diabetes mellitus	0.00024	0.00197	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000238	0.00195	CcSEcCtD
Methimazole—Vertigo—Valsartan—type 2 diabetes mellitus	0.000237	0.00195	CcSEcCtD
Methimazole—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000234	0.00192	CcSEcCtD
Methimazole—Vertigo—Orlistat—type 2 diabetes mellitus	0.000234	0.00192	CcSEcCtD
Methimazole—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00023	0.00189	CcSEcCtD
Methimazole—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00023	0.00189	CcSEcCtD
Methimazole—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.00023	0.00188	CcSEcCtD
Methimazole—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000229	0.00188	CcSEcCtD
Methimazole—Jaundice—Ramipril—type 2 diabetes mellitus	0.000228	0.00187	CcSEcCtD
Methimazole—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000227	0.00186	CcSEcCtD
Methimazole—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000226	0.00185	CcSEcCtD
Methimazole—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000225	0.00184	CcSEcCtD
Methimazole—Myalgia—Valsartan—type 2 diabetes mellitus	0.000225	0.00184	CcSEcCtD
Methimazole—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000224	0.00184	CcSEcCtD
Methimazole—Myalgia—Orlistat—type 2 diabetes mellitus	0.000222	0.00182	CcSEcCtD
Methimazole—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000218	0.00179	CcSEcCtD
Methimazole—Alopecia—Losartan—type 2 diabetes mellitus	0.000217	0.00178	CcSEcCtD
Methimazole—Vomiting—Glipizide—type 2 diabetes mellitus	0.000216	0.00177	CcSEcCtD
Methimazole—Oedema—Valsartan—type 2 diabetes mellitus	0.000215	0.00177	CcSEcCtD
Methimazole—Rash—Glipizide—type 2 diabetes mellitus	0.000214	0.00176	CcSEcCtD
Methimazole—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000214	0.00175	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000214	0.00175	CcSEcCtD
Methimazole—Oedema—Orlistat—type 2 diabetes mellitus	0.000213	0.00175	CcSEcCtD
Methimazole—Headache—Glipizide—type 2 diabetes mellitus	0.000212	0.00174	CcSEcCtD
Methimazole—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000211	0.00173	CcSEcCtD
Methimazole—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00021	0.00173	CcSEcCtD
Methimazole—Hepatitis—Ramipril—type 2 diabetes mellitus	0.00021	0.00173	CcSEcCtD
Methimazole—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000208	0.00171	CcSEcCtD
Methimazole—Urticaria—Glyburide—type 2 diabetes mellitus	0.000207	0.0017	CcSEcCtD
Methimazole—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000206	0.00169	CcSEcCtD
Methimazole—Myalgia—Metformin—type 2 diabetes mellitus	0.000205	0.00168	CcSEcCtD
Methimazole—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000204	0.00167	CcSEcCtD
Methimazole—Headache—Pioglitazone—type 2 diabetes mellitus	0.000204	0.00167	CcSEcCtD
Methimazole—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000203	0.00167	CcSEcCtD
Methimazole—Nausea—Glipizide—type 2 diabetes mellitus	0.000201	0.00165	CcSEcCtD
Methimazole—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000201	0.00165	CcSEcCtD
Methimazole—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000201	0.00165	CcSEcCtD
Methimazole—Rash—Glimepiride—type 2 diabetes mellitus	0.0002	0.00164	CcSEcCtD
Methimazole—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000199	0.00164	CcSEcCtD
Methimazole—Rash—Sitagliptin—type 2 diabetes mellitus	0.000199	0.00163	CcSEcCtD
Methimazole—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000199	0.00163	CcSEcCtD
Methimazole—Headache—Glimepiride—type 2 diabetes mellitus	0.000198	0.00163	CcSEcCtD
Methimazole—Headache—Sitagliptin—type 2 diabetes mellitus	0.000198	0.00162	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000196	0.00161	CcSEcCtD
Methimazole—Oedema—Metformin—type 2 diabetes mellitus	0.000196	0.00161	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000194	0.00159	CcSEcCtD
Methimazole—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000193	0.00159	CcSEcCtD
Methimazole—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000193	0.00158	CcSEcCtD
Methimazole—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000193	0.00158	CcSEcCtD
Methimazole—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000192	0.00158	CcSEcCtD
Methimazole—Vertigo—Losartan—type 2 diabetes mellitus	0.000192	0.00157	CcSEcCtD
Methimazole—Somnolence—Valsartan—type 2 diabetes mellitus	0.000191	0.00157	CcSEcCtD
Methimazole—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000191	0.00157	CcSEcCtD
Methimazole—Leukopenia—Losartan—type 2 diabetes mellitus	0.000191	0.00157	CcSEcCtD
Methimazole—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00019	0.00156	CcSEcCtD
Methimazole—Nausea—Glimepiride—type 2 diabetes mellitus	0.000188	0.00154	CcSEcCtD
Methimazole—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000187	0.00154	CcSEcCtD
Methimazole—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000187	0.00154	CcSEcCtD
Methimazole—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000186	0.00153	CcSEcCtD
Methimazole—Alopecia—Ramipril—type 2 diabetes mellitus	0.000186	0.00152	CcSEcCtD
Methimazole—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000185	0.00152	CcSEcCtD
Methimazole—Oedema—Irbesartan—type 2 diabetes mellitus	0.000185	0.00152	CcSEcCtD
Methimazole—Pruritus—Glyburide—type 2 diabetes mellitus	0.000185	0.00152	CcSEcCtD
Methimazole—Myalgia—Losartan—type 2 diabetes mellitus	0.000182	0.00149	CcSEcCtD
Methimazole—Arthralgia—Losartan—type 2 diabetes mellitus	0.000182	0.00149	CcSEcCtD
Methimazole—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000182	0.00149	CcSEcCtD
Methimazole—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000181	0.00149	CcSEcCtD
Methimazole—Rash—Bromocriptine—type 2 diabetes mellitus	0.00018	0.00148	CcSEcCtD
Methimazole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00018	0.00148	CcSEcCtD
Methimazole—Headache—Bromocriptine—type 2 diabetes mellitus	0.000179	0.00147	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000179	0.00147	CcSEcCtD
Methimazole—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000176	0.00145	CcSEcCtD
Methimazole—Somnolence—Metformin—type 2 diabetes mellitus	0.000174	0.00143	CcSEcCtD
Methimazole—Oedema—Losartan—type 2 diabetes mellitus	0.000174	0.00143	CcSEcCtD
Methimazole—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000173	0.00142	CcSEcCtD
Methimazole—Urticaria—Valsartan—type 2 diabetes mellitus	0.000171	0.0014	CcSEcCtD
Methimazole—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000171	0.0014	CcSEcCtD
Methimazole—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00017	0.00139	CcSEcCtD
Methimazole—Urticaria—Orlistat—type 2 diabetes mellitus	0.000169	0.00139	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000169	0.00138	CcSEcCtD
Methimazole—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000168	0.00138	CcSEcCtD
Methimazole—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000166	0.00136	CcSEcCtD
Methimazole—Vomiting—Glyburide—type 2 diabetes mellitus	0.000166	0.00136	CcSEcCtD
Methimazole—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000166	0.00136	CcSEcCtD
Methimazole—Rash—Glyburide—type 2 diabetes mellitus	0.000165	0.00135	CcSEcCtD
Methimazole—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000165	0.00135	CcSEcCtD
Methimazole—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000164	0.00135	CcSEcCtD
Methimazole—Vertigo—Ramipril—type 2 diabetes mellitus	0.000164	0.00135	CcSEcCtD
Methimazole—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000164	0.00134	CcSEcCtD
Methimazole—Headache—Glyburide—type 2 diabetes mellitus	0.000164	0.00134	CcSEcCtD
Methimazole—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000163	0.00134	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000159	0.0013	CcSEcCtD
Methimazole—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000156	0.00128	CcSEcCtD
Methimazole—Urticaria—Metformin—type 2 diabetes mellitus	0.000156	0.00128	CcSEcCtD
Methimazole—Myalgia—Ramipril—type 2 diabetes mellitus	0.000156	0.00128	CcSEcCtD
Methimazole—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000156	0.00128	CcSEcCtD
Methimazole—Nausea—Glyburide—type 2 diabetes mellitus	0.000155	0.00127	CcSEcCtD
Methimazole—Somnolence—Losartan—type 2 diabetes mellitus	0.000155	0.00127	CcSEcCtD
Methimazole—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000153	0.00126	CcSEcCtD
Methimazole—Pruritus—Valsartan—type 2 diabetes mellitus	0.000152	0.00125	CcSEcCtD
Methimazole—Pruritus—Orlistat—type 2 diabetes mellitus	0.000151	0.00124	CcSEcCtD
Methimazole—Oedema—Ramipril—type 2 diabetes mellitus	0.000149	0.00123	CcSEcCtD
Methimazole—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000149	0.00122	CcSEcCtD
Methimazole—Rash—Gliclazide—type 2 diabetes mellitus	0.000148	0.00121	CcSEcCtD
Methimazole—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000148	0.00121	CcSEcCtD
Methimazole—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000147	0.00121	CcSEcCtD
Methimazole—Headache—Gliclazide—type 2 diabetes mellitus	0.000147	0.00121	CcSEcCtD
Methimazole—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000146	0.0012	CcSEcCtD
Methimazole—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000146	0.0012	CcSEcCtD
Methimazole—Nausea—Gliclazide—type 2 diabetes mellitus	0.000139	0.00114	CcSEcCtD
Methimazole—Pruritus—Metformin—type 2 diabetes mellitus	0.000139	0.00114	CcSEcCtD
Methimazole—Urticaria—Losartan—type 2 diabetes mellitus	0.000138	0.00114	CcSEcCtD
Methimazole—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000138	0.00113	CcSEcCtD
Methimazole—Vomiting—Valsartan—type 2 diabetes mellitus	0.000137	0.00112	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000136	0.00112	CcSEcCtD
Methimazole—Rash—Valsartan—type 2 diabetes mellitus	0.000136	0.00111	CcSEcCtD
Methimazole—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000136	0.00111	CcSEcCtD
Methimazole—Vomiting—Orlistat—type 2 diabetes mellitus	0.000135	0.00111	CcSEcCtD
Methimazole—Headache—Valsartan—type 2 diabetes mellitus	0.000135	0.00111	CcSEcCtD
Methimazole—Rash—Orlistat—type 2 diabetes mellitus	0.000134	0.0011	CcSEcCtD
Methimazole—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000134	0.0011	CcSEcCtD
Methimazole—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000134	0.0011	CcSEcCtD
Methimazole—Headache—Orlistat—type 2 diabetes mellitus	0.000133	0.00109	CcSEcCtD
Methimazole—Somnolence—Ramipril—type 2 diabetes mellitus	0.000133	0.00109	CcSEcCtD
Methimazole—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000131	0.00108	CcSEcCtD
Methimazole—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000131	0.00107	CcSEcCtD
Methimazole—Nausea—Valsartan—type 2 diabetes mellitus	0.000128	0.00105	CcSEcCtD
Methimazole—Nausea—Orlistat—type 2 diabetes mellitus	0.000126	0.00104	CcSEcCtD
Methimazole—Vomiting—Metformin—type 2 diabetes mellitus	0.000125	0.00102	CcSEcCtD
Methimazole—Rash—Metformin—type 2 diabetes mellitus	0.000124	0.00101	CcSEcCtD
Methimazole—Dermatitis—Metformin—type 2 diabetes mellitus	0.000124	0.00101	CcSEcCtD
Methimazole—Pruritus—Losartan—type 2 diabetes mellitus	0.000123	0.00101	CcSEcCtD
Methimazole—Headache—Metformin—type 2 diabetes mellitus	0.000123	0.00101	CcSEcCtD
Methimazole—Urticaria—Ramipril—type 2 diabetes mellitus	0.000119	0.000974	CcSEcCtD
Methimazole—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000118	0.000969	CcSEcCtD
Methimazole—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000118	0.000966	CcSEcCtD
Methimazole—Rash—Irbesartan—type 2 diabetes mellitus	0.000117	0.000958	CcSEcCtD
Methimazole—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000117	0.000957	CcSEcCtD
Methimazole—Nausea—Metformin—type 2 diabetes mellitus	0.000116	0.000956	CcSEcCtD
Methimazole—Headache—Irbesartan—type 2 diabetes mellitus	0.000116	0.000951	CcSEcCtD
Methimazole—Vomiting—Losartan—type 2 diabetes mellitus	0.000111	0.000909	CcSEcCtD
Methimazole—Nausea—Irbesartan—type 2 diabetes mellitus	0.00011	0.000902	CcSEcCtD
Methimazole—Rash—Losartan—type 2 diabetes mellitus	0.00011	0.000901	CcSEcCtD
Methimazole—Dermatitis—Losartan—type 2 diabetes mellitus	0.00011	0.0009	CcSEcCtD
Methimazole—Headache—Losartan—type 2 diabetes mellitus	0.000109	0.000895	CcSEcCtD
Methimazole—Pruritus—Ramipril—type 2 diabetes mellitus	0.000106	0.000867	CcSEcCtD
Methimazole—Nausea—Losartan—type 2 diabetes mellitus	0.000103	0.000849	CcSEcCtD
Methimazole—Vomiting—Ramipril—type 2 diabetes mellitus	9.49e-05	0.000779	CcSEcCtD
Methimazole—Rash—Ramipril—type 2 diabetes mellitus	9.42e-05	0.000773	CcSEcCtD
Methimazole—Dermatitis—Ramipril—type 2 diabetes mellitus	9.41e-05	0.000772	CcSEcCtD
Methimazole—Headache—Ramipril—type 2 diabetes mellitus	9.35e-05	0.000768	CcSEcCtD
Methimazole—Nausea—Ramipril—type 2 diabetes mellitus	8.87e-05	0.000728	CcSEcCtD
Methimazole—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4.93e-06	7.92e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	4.92e-06	7.9e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	4.9e-06	7.88e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.9e-06	7.88e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	4.89e-06	7.86e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	4.89e-06	7.86e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	4.89e-06	7.86e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.88e-06	7.84e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.85e-06	7.79e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.85e-06	7.79e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	4.84e-06	7.78e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	4.82e-06	7.76e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	4.81e-06	7.74e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	4.8e-06	7.71e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.79e-06	7.71e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	4.78e-06	7.68e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	4.78e-06	7.68e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.75e-06	7.64e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.73e-06	7.6e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	4.73e-06	7.6e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	4.72e-06	7.59e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	4.71e-06	7.57e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.7e-06	7.56e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.69e-06	7.54e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.69e-06	7.54e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.68e-06	7.53e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.68e-06	7.53e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.66e-06	7.49e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	4.66e-06	7.48e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	4.66e-06	7.48e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	4.66e-06	7.48e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.65e-06	7.48e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.65e-06	7.47e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.65e-06	7.47e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.63e-06	7.44e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	4.63e-06	7.44e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	4.61e-06	7.41e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	4.58e-06	7.37e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.54e-06	7.31e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.53e-06	7.28e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.52e-06	7.27e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.52e-06	7.27e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.52e-06	7.27e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.52e-06	7.27e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.51e-06	7.25e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.49e-06	7.22e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	4.49e-06	7.22e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.47e-06	7.18e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.46e-06	7.17e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.46e-06	7.17e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.43e-06	7.13e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.42e-06	7.1e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.42e-06	7.1e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	4.37e-06	7.02e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.35e-06	6.99e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	4.34e-06	6.98e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.34e-06	6.97e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.31e-06	6.93e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.29e-06	6.89e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	4.28e-06	6.88e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.27e-06	6.87e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.27e-06	6.87e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	4.26e-06	6.85e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	4.25e-06	6.84e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	4.24e-06	6.81e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	4.24e-06	6.81e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.19e-06	6.73e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.18e-06	6.71e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.18e-06	6.71e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.18e-06	6.71e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	4.17e-06	6.71e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	4.13e-06	6.64e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.1e-06	6.59e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.06e-06	6.53e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	4.06e-06	6.53e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	4.04e-06	6.5e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	4.04e-06	6.5e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.03e-06	6.48e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.01e-06	6.44e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	4e-06	6.44e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	4e-06	6.44e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	4e-06	6.43e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.99e-06	6.41e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.98e-06	6.39e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.97e-06	6.39e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.96e-06	6.37e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.93e-06	6.32e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	3.93e-06	6.31e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.92e-06	6.3e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.82e-06	6.14e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.82e-06	6.14e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.78e-06	6.07e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.76e-06	6.05e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	3.76e-06	6.04e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.76e-06	6.04e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.71e-06	5.97e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.69e-06	5.93e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.69e-06	5.93e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.68e-06	5.92e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.68e-06	5.92e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.68e-06	5.92e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.67e-06	5.89e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.66e-06	5.89e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.65e-06	5.87e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.65e-06	5.87e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.65e-06	5.86e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.63e-06	5.84e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.62e-06	5.82e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.62e-06	5.82e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.62e-06	5.82e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.62e-06	5.81e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.59e-06	5.78e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.59e-06	5.78e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.59e-06	5.78e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.59e-06	5.77e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.57e-06	5.74e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.57e-06	5.74e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.56e-06	5.72e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	3.52e-06	5.66e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.51e-06	5.65e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.51e-06	5.64e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.48e-06	5.6e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.47e-06	5.57e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.46e-06	5.57e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	3.45e-06	5.55e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	3.45e-06	5.55e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	3.43e-06	5.52e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.42e-06	5.5e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.42e-06	5.49e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.39e-06	5.45e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	3.38e-06	5.44e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.35e-06	5.39e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.32e-06	5.34e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.28e-06	5.28e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.28e-06	5.28e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.27e-06	5.26e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.25e-06	5.23e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.24e-06	5.21e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.22e-06	5.18e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.22e-06	5.18e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.22e-06	5.18e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.22e-06	5.18e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.19e-06	5.12e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	3.17e-06	5.09e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.16e-06	5.09e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.16e-06	5.08e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.15e-06	5.06e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.13e-06	5.04e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.12e-06	5.02e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.12e-06	5.02e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.12e-06	5.01e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	3.12e-06	5.01e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.11e-06	4.99e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	3.1e-06	4.99e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.07e-06	4.93e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.07e-06	4.93e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.06e-06	4.93e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.06e-06	4.91e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.03e-06	4.87e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	3.03e-06	4.87e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.02e-06	4.86e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.02e-06	4.85e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.99e-06	4.81e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.98e-06	4.78e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.97e-06	4.77e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.97e-06	4.77e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.96e-06	4.76e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.95e-06	4.74e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.94e-06	4.72e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.91e-06	4.69e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.91e-06	4.69e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.89e-06	4.65e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.87e-06	4.61e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.84e-06	4.57e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.84e-06	4.57e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.82e-06	4.54e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.81e-06	4.52e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.8e-06	4.5e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.79e-06	4.49e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.79e-06	4.49e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.79e-06	4.48e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.78e-06	4.47e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.78e-06	4.47e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.77e-06	4.46e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.77e-06	4.46e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.75e-06	4.43e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.71e-06	4.36e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.7e-06	4.34e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.67e-06	4.29e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.66e-06	4.28e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.61e-06	4.2e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.56e-06	4.11e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.51e-06	4.03e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.45e-06	3.94e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.43e-06	3.91e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.43e-06	3.9e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.41e-06	3.87e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.41e-06	3.87e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.4e-06	3.86e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.4e-06	3.85e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.39e-06	3.85e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.39e-06	3.84e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.38e-06	3.83e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.38e-06	3.83e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.37e-06	3.8e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.35e-06	3.78e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.3e-06	3.69e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.29e-06	3.68e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.29e-06	3.68e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.23e-06	3.59e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.2e-06	3.54e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.19e-06	3.52e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.18e-06	3.51e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.15e-06	3.45e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.14e-06	3.44e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.11e-06	3.39e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.11e-06	3.39e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.09e-06	3.37e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.09e-06	3.36e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.09e-06	3.36e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.08e-06	3.35e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.07e-06	3.33e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.06e-06	3.31e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.03e-06	3.27e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.97e-06	3.17e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.94e-06	3.11e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.93e-06	3.1e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.91e-06	3.07e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.88e-06	3.02e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.86e-06	3e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.84e-06	2.97e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.84e-06	2.95e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.82e-06	2.92e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.78e-06	2.87e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.78e-06	2.87e-05	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	1.73e-06	2.78e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.63e-06	2.62e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.6e-06	2.57e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.57e-06	2.52e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.44e-06	2.31e-05	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.39e-06	2.24e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.38e-06	2.21e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.38e-06	2.21e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.36e-06	2.19e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.26e-06	2.02e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.05e-06	1.69e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	9.68e-07	1.56e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	9.6e-07	1.54e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	8.2e-07	1.32e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.33e-07	1.02e-05	CbGpPWpGaD
